Azafaros Switzerland ^Company

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders, through oral administration of azasugar compounds. With the proprietary small molecule compounds, the company provides treatments for patients suffering from LSDs and LSD-related diseases.